Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 4
Submit an article Journal homepage
1,324
Views
0
CrossRef citations to date
0
Altmetric
Hematology

Real-world characteristics of patients with sickle cell disease who initiated crizanlizumab therapy

Payal C. Desaia Hematology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA
,
Chi-Chang Chenb IQVIA Inc, Wayne, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7065-9607
ORCID Icon,
Catherine B. McGuinessb IQVIA Inc, Wayne, PA, USAORCID Iconhttps://orcid.org/0000-0002-5367-6472
ORCID Icon,
Marie Yasudab IQVIA Inc, Wayne, PA, USA
,
Soyon Leec Novartis, East Hanover, NJ, USAORCID Iconhttps://orcid.org/0000-0002-2059-717X
ORCID Icon,
Jincy Paulosec Novartis, East Hanover, NJ, USA
,
Jing Heb IQVIA Inc, Wayne, PA, USA
&
Glorian Yenc Novartis, East Hanover, NJ, USA
 show all
Pages 555-565 | Received 05 Oct 2022, Accepted 22 Feb 2023, Published online: 11 Mar 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.